Trial of baclofen in amyotrophic lateral sclerosis
- PMID: 508132
- DOI: 10.1001/archneur.1979.00500470085019
Trial of baclofen in amyotrophic lateral sclerosis
Abstract
A trial of the antispastic drug baclofen was made in amyotrophic lateral sclerosis. Some patients noted reduction of tonus and spasticity; but others had no benefit, nor was the course of the disease altered by long-term administration of baclofen. No major side effects occurred.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources